Annual Report FY2025-26 and Notice of 32nd AGM on Sept 29, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Parmax Pharma filed its Annual Report for FY2025-26 (year ended March 31, 2026) along with notice of its 32nd AGM to be held on September 29, 2026 at 3:30 PM via video conferencing. Remote e-voting runs from September 26 to 28, 2026 with cut-off date September 22, 2026. AGM items include adoption of financial statements, re-appointment of Managing Director Umang Gosalia, appointment of Dhiren Shah as Non-Executive Chairman, Sunil Shah as Non-Executive Director, and two independent directors for 5-year terms.
Shareholders can review the annual report and vote on resolutions including director appointments at the upcoming virtual AGM.